tiprankstipranks
Trending News
More News >
Satellos Bioscience (TSE:MSCL)
TSX:MSCL
Canadian Market

Satellos Bioscience (MSCL) Financial Statements

Compare
27 Followers

Satellos Bioscience Financial Overview

Satellos Bioscience's market cap is currently $154.90M. The company's EPS TTM is C$-0.042; its P/E ratio is -4.42; Satellos Bioscience is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -20.00KC$ -8.82MC$ -3.73MC$ -119.92KC$ -48.16K
Operating IncomeC$ -27.81MC$ -15.46MC$ -8.43MC$ -4.74MC$ -1.55M
EBITDAC$ -28.08MC$ -15.71MC$ -8.09MC$ -4.60MC$ -1.61M
Net IncomeC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58M
Balance Sheet
Cash & Short-Term InvestmentsC$ 69.85MC$ 39.59MC$ 1.92MC$ 4.87MC$ 717.53K
Total AssetsC$ 73.02MC$ 44.30MC$ 6.20MC$ 12.59MC$ 1.13M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 1.09M
Net DebtC$ -57.66MC$ -22.07MC$ -1.92MC$ -4.87MC$ 375.78K
Total LiabilitiesC$ 5.16MC$ 3.62MC$ 2.83MC$ 2.10MC$ 1.31M
Stockholders' EquityC$ 67.86MC$ 40.67MC$ 3.37MC$ 10.48MC$ -183.84K
Cash Flow
Free Cash FlowC$ -24.98MC$ -14.52MC$ -5.79MC$ -5.04MC$ -1.66M
Operating Cash FlowC$ -24.98MC$ -14.50MC$ -5.78MC$ -5.03MC$ -1.66M
Investing Cash FlowC$ 6.34MC$ -17.54MC$ -3.00KC$ 1.74MC$ 0.00
Financing Cash FlowC$ 53.48MC$ 51.03MC$ 2.77MC$ 7.45MC$ 1.98M
Currency in CAD

Satellos Bioscience Earnings and Revenue History

Satellos Bioscience Debt to Assets

Satellos Bioscience Cash Flow

Satellos Bioscience Forecast EPS vs Actual EPS